differ
form
sar
coronaviru
sarscov
spike
proteinbas
vaccin
gener
neutral
antibodi
respons
sarscov
compar
use
mous
model
high
igg
level
detect
mice
immun
intraperiton
ip
recombin
spike
polypeptid
gener
escherichia
coli
speptid
mice
prime
intramuscular
im
dna
vaccin
tpasdna
boost
sever
acut
respiratori
syndrom
sar
affect
countri
five
contin
case
death
novel
viru
sar
coronaviru
sarscov
confirm
etiolog
agent
addit
also
report
isol
sarscovlik
virus
himalayan
palm
civet
found
live
anim
market
guangdong
provinc
china
impli
anim
could
reservoir
ancestor
sarscov
anim
coronaviru
infect
shown
spike
protein
coronavirus
highli
immunogen
immun
anim
use
spike
proteinbas
vaccin
abl
produc
neutral
antibodi
effect
prevent
infect
caus
correspond
coronavirus
sarscov
infect
shown
nucleotid
spike
protein
gene
sarscov
encod
acid
fragment
respons
attach
receptor
sarscov
angiotensinconvert
enzym
furthermor
also
other
shown
patient
sar
produc
antibodi
respons
spike
protein
sarscov
demonstr
spike
protein
major
target
passiv
immun
studi
determin
rel
import
humor
cell
mediat
immun
protect
sarscov
infect
confirm
neutral
antibodi
administ
passiv
immun
crucial
confer
protect
wherea
tcell
immun
unabl
lead
protect
addit
vaccin
candid
sarscov
spike
proteinbas
dna
vaccin
appear
promis
group
vaccin
shown
produc
protect
immun
sarscov
infect
wherea
recombin
spike
protein
vaccin
produc
escherichia
coli
effici
term
gener
protect
immun
compar
gener
eukaryot
system
transfect
cell
line
howev
multipl
dose
intramuscularli
im
administ
dna
vaccin
recombin
protein
gener
eukaryot
system
quit
expens
therefor
may
practic
develop
countri
data
less
expens
modal
immun
dna
vaccin
follow
booster
recombin
vaccin
produc
e
coli
oral
mucos
dna
vaccin
avail
studi
compar
differ
form
sarscov
spike
proteinbas
vaccin
gener
neutral
antibodi
respons
sarscov
use
mous
model
rel
effect
recombin
spike
polypeptid
vaccin
produc
e
coli
two
differ
type
intramuscular
spike
polypeptid
dna
vaccin
without
booster
recombin
spike
polypeptid
vaccin
produc
e
coli
two
differ
type
oral
mucos
spike
polypeptid
dna
vaccin
without
booster
recombin
spike
polypeptid
vaccin
produc
e
coli
compar
male
balbc
mice
week
old
g
use
anim
experi
hous
cage
standard
condit
regul
day
length
temperatur
humid
given
pellet
food
tap
water
ad
libitum
clone
purif
spike
polypeptid
sarscov
report
previous
briefli
produc
plasmid
protein
express
primer
use
amplifi
gene
encod
amino
acid
residu
spike
protein
sarscov
rtpcr
portion
spike
protein
use
contain
receptorbind
domain
within
domain
highli
immunogen
wherea
complet
spike
protein
express
e
coli
pcr
product
clone
bamhi
kpni
site
vector
qiagen
hilden
germani
result
clone
digest
psti
psti
fragment
contain
gene
encod
amino
acid
residu
spike
protein
clone
express
vector
qiagen
hilden
germani
frame
downstream
seri
six
histidin
residu
tag
recombin
spike
polypeptid
speptid
express
purifi
use
ni
load
hitrap
chelat
system
amersham
pharmacia
usa
accord
manufactur
instruct
enhanc
express
spike
polypeptid
human
cell
two
sarscov
dna
vaccin
tpasdna
construct
use
concept
human
codon
usag
optim
quikchang
multi
sitedirect
mutagenesi
kit
strategen
usa
accord
manufactur
instruct
synthet
polypeptid
clone
oral
mucos
dna
vaccin
salmonellatpasdna
prepar
accord
publish
protocol
tpasdna
transform
auxotroph
typhimurium
aroa
strain
typhimurium
deriv
del
aroa
tc
gift
dr
bruce
stocker
electropor
transfect
cell
tpasdna
perform
accord
publish
protocol
two
hundr
ninetythre
cell
plate
cell
per
well
dulbecco
modifi
eagl
medium
gibcobrl
usa
fetal
calf
serum
fc
sixwel
plate
day
transfect
day
transfect
well
transfect
g
plasmid
encod
eukaryot
express
sarscov
spike
polypeptid
tpasdna
sdnacontrol
fugen
reagent
boehring
mannhein
germani
accord
manufactur
instruct
fortyeight
hour
transfect
cell
harvest
lyse
freez
thaw
three
time
centrifug
rpm
supernat
use
detect
sarscov
spike
polypeptid
western
blot
assay
use
preimmun
rabbit
serum
hyperimmun
polyclon
serum
rabbit
immun
speptid
western
blot
analysi
perform
accord
publish
protocol
briefli
l
supernat
cell
lysat
obtain
cell
transfect
tpasdna
sdnacontrol
load
well
sodium
dodecyl
sulfat
sd
polyacrylamid
gel
subsequ
electroblot
onto
nitrocellulos
membran
biorad
hercul
ca
usa
blot
incub
separ
dilut
preimmun
rabbit
serum
hyperimmun
polyclon
serum
rabbit
immun
speptid
antigenantibodi
interact
detect
ecl
fluoresc
system
amersham
life
scienc
buckinghamshir
uk
seventytwo
balbc
mice
use
immun
experi
immun
schedul
summar
tabl
day
six
mice
immun
intraperiton
ip
speptid
g
per
mous
group
tabl
day
six
mice
immun
im
tibiali
anterior
muscl
sdnacontrol
g
per
mous
group
tabl
mice
immun
im
tpasdna
g
per
mous
group
tabl
g
per
mous
group
tabl
day
mice
two
dna
vaccin
group
boost
ip
speptid
g
per
mous
group
tabl
day
mice
immun
oral
typhimurium
aroa
strain
salmonellasdnacontrol
bacteri
cell
per
mous
group
tabl
salmonellatpasdna
bacteri
cell
per
mous
group
tabl
bacteri
cell
per
mous
group
tabl
day
mice
three
group
boost
ip
speptid
g
per
mous
group
tabl
tabl
immun
mice
group
bled
day
immun
day
last
dose
vaccin
correspond
group
blood
centrifug
g
min
supernat
serum
store
c
antibodi
measur
antibodi
sarscov
spike
polypeptid
measur
use
enzymelink
immunosorb
assay
elisa
accord
publish
protocol
modif
mous
sera
dilut
skim
milk
igm
igg
ad
elisa
plate
precoat
speptid
ng
per
well
igm
igg
ng
per
well
plate
incub
c
h
wash
wash
buffer
five
time
l
peroxidaseconjug
goat
antimous
igm
igg
rabbit
antimous
rat
antimous
antibodi
zyme
laboratori
inc
usa
dilut
accord
manufactur
instruct
use
skim
milk
ad
correspond
well
accordingli
incub
c
h
igm
total
igg
level
assay
assess
primari
secondari
immun
respons
igg
subtyp
use
determin
whether
humor
respons
inclin
toward
pattern
wash
wash
buffer
five
time
l
dilut
tetramethylbenzidin
zyme
laboratori
inc
ad
well
incub
room
temperatur
min
one
hundr
microlit
h
ad
absorb
nm
well
measur
sampl
test
duplic
mean
absorb
serum
calcul
serum
antibodi
level
particular
mous
defin
absorb
obtain
serum
taken
day
last
dose
vaccin
minu
correspond
mous
taken
day
immun
index
mous
calcul
follow
formula
neutral
antibodi
assay
modifi
publish
protocol
work
infecti
viru
perform
insid
type
ii
biosafeti
cabinet
biosafeti
contain
level
iii
facil
personnel
wore
power
airpurifi
respir
hepa
airmat
st
paul
mn
initi
screen
mous
sera
prototyp
sarscov
strain
perform
microtit
plate
seed
fetal
rhesu
cell
twofold
dilut
mous
sera
test
duplic
tcid
sarscov
correspond
set
cell
control
sera
without
viru
inocul
use
control
cell
score
inhibit
cytopath
effect
cpe
h
titer
neutral
antibodi
defin
maximum
dilut
serum
percentag
cpe
less
equal
lpi
measur
accord
publish
protocol
day
singlecel
suspens
spleen
cell
six
mice
group
deplet
erythrocyt
ad
freshli
prepar
gey
solut
cell
resuspend
rpmi
medium
gibco
brl
rockvil
md
supplement
fetal
calf
serum
inocul
microwel
plate
cell
per
well
triplic
cell
stimul
phytohaemagglutinin
g
per
well
posit
control
speptid
g
per
well
rpmi
medium
neg
control
cell
cultur
c
co
day
hlabel
thymidin
amersham
pharmacia
littl
chalfont
uk
ad
ci
per
well
last
h
cell
harvest
onto
glass
microfibr
filter
whatman
intern
ltd
uk
use
model
cell
harvest
insel
hampshir
uk
radioact
measur
liquid
scintil
counter
beckman
fullerton
ca
speptidespecif
lpi
particular
sampl
defin
ratio
differ
radioact
sampl
neg
control
posit
neg
control
assay
accord
publish
protocol
day
spleen
six
mice
group
harvest
singlecel
suspens
prepar
cell
mice
within
group
pool
cell
cultur
ml
rpmi
medium
supplement
fetal
calf
serum
plate
speptid
ad
final
concentr
gml
supernat
l
sampl
collect
h
cytokin
measur
monoclon
antibodi
coat
onto
well
microtit
plate
opteia
becton
dickinson
usa
dilut
accord
manufactur
instruct
plate
incub
rt
h
wash
wash
buffer
three
time
plate
block
assay
diluent
rt
h
wash
wash
buffer
three
time
l
supernat
sampl
ad
well
duplic
plate
incub
rt
h
wash
wash
buffer
five
time
l
dilut
biotinyl
antibodi
avidinhorseradish
peroxidas
conjug
ad
well
incub
rt
h
wash
wash
buffer
eight
time
l
tmb
substrat
ad
well
incub
rt
min
hundr
microlit
h
ad
absorb
well
measur
nm
use
tmb
buffer
blank
pool
sampl
test
triplic
mean
absorb
pool
sampl
calcul
comparison
made
among
serum
antibodi
level
lpi
variou
group
mice
use
oneway
anova
p
regard
statist
signific
supernat
cell
lysat
obtain
cell
transfect
tpasdna
sdnacontrol
separ
sdspolyacrylamid
gel
follow
western
blot
analysi
sera
preimmun
rabbit
serum
hyperimmun
polyclon
serum
rabbit
immun
speptid
promin
immunoreact
protein
band
kda
visibl
western
blot
use
cell
lysat
obtain
cell
transfect
tpasdna
respect
antigen
hyperimmun
polyclon
serum
rabbit
immun
speptid
sourc
antibodi
fig
lane
size
consist
expect
size
kda
correspond
spike
polypeptid
antibodi
level
group
mice
day
summar
fig
igg
detect
mice
group
wherea
high
igg
level
detect
mice
group
statist
signific
differ
observ
among
index
among
six
group
mice
high
igg
level
number
mice
differ
neutral
antibodi
titer
immun
differ
form
spike
polypeptidebas
vaccin
sarscov
shown
tabl
speptidespecif
lpi
group
mice
day
summar
fig
signific
lymphocyt
prolifer
detect
group
compar
control
group
group
h
undetect
group
mice
three
concentr
speptid
data
shown
h
detect
mice
group
data
shown
h
detect
mice
group
fig
h
level
group
mice
shown
fig
detect
mice
group
h
level
mice
group
pgml
data
shown
tabl
bar
averag
six
mice
error
bar
standard
deviat
among
combin
vaccin
examin
studi
mice
prime
sarscov
human
codon
usag
optim
spike
polypeptid
dna
vaccin
boost
speptid
produc
e
coli
gener
highest
titer
neutral
antibodi
sarscov
observ
confirm
present
studi
speptid
produc
e
coli
induc
neutral
antibodi
sarscov
infect
tabl
group
hand
recombin
spike
polypeptid
gener
eukaryot
system
transfect
cell
dna
vaccin
abl
elicit
high
neutral
antibodi
titer
sarscov
infect
probabl
speptid
produc
e
coli
use
three
dimension
fold
andor
glycosyl
speptid
optim
gener
neutral
antibodi
studi
document
although
recombin
speptid
produc
e
coli
abl
gener
neutral
antibodi
sarscov
tabl
neutral
antibodi
titer
differ
form
spike
polypeptidebas
vaccin
sarscov
neutral
tabl
group
indic
type
vaccin
use
prime
crucial
determin
type
immun
respons
develop
subsequ
dose
booster
immun
respons
gener
first
dose
vaccin
note
humor
immun
respons
develop
mice
prime
spike
polypeptid
dna
vaccin
boost
speptid
e
coli
particularli
type
compar
develop
mice
immun
speptid
e
coli
alon
indic
type
immun
respons
may
essenti
gener
neutral
antibodi
sarscov
although
result
suggest
prime
dna
vaccin
boost
speptid
produc
e
coli
success
gener
neutral
antibodi
sarscov
experi
use
infect
model
evalu
protect
immun
warrant
sinc
antispik
antibodi
shown
enhanc
infect
coronavirus
cell
cultur
system
occur
sarscov
felin
infecti
periton
viru
present
observ
may
major
practic
valu
immun
civet
cat
product
recombin
protein
e
coli
far
less
expens
product
recombin
protein
use
eukaryot
system
transfect
cell
line
dna
vaccin
although
shown
dna
vaccin
abl
gener
humor
cellular
immun
success
variou
pathogen
mice
one
major
limit
clinic
use
ineffect
use
human
unless
larg
amount
dna
use
immun
product
recombin
spike
polypeptid
gener
eukaryot
system
transfect
cell
use
baculoviru
system
although
conform
andor
glycosyl
spike
polypeptid
produc
theoret
similar
nativ
viral
spike
protein
easi
scale
product
recombin
protein
industri
level
contrast
recombin
spike
polypeptid
gener
fig
sarscov
spike
polypeptidespecif
lymphocyt
prolifer
index
balbc
mice
immun
variou
vaccin
group
correspond
group
mice
describ
tabl
bar
averag
six
mice
error
bar
standard
deviat
tabl
eukaryot
system
larg
amount
speptid
produc
e
coli
rel
inexpens
way
speptid
use
success
booster
studi
effect
mode
vaccin
gener
protect
immun
sarscov
anim
could
perform
principl
also
examin
vaccin
pathogen
effect
modal
vaccin
dna
vaccin
use
prime
less
expens
recombin
protein
produc
e
coli
instead
eukaryot
system
use
booster
spike
polypeptid
dna
vaccin
deliv
liveattenu
salmonella
system
induc
good
neutral
antibodi
sarscov
infect
previous
shown
hepat
b
viru
dna
vaccin
present
liveattenu
salmonella
system
gener
good
cytotox
lymphocyt
respons
minim
antibodi
respons
hepat
b
viru
mous
model
furthermor
found
immun
respons
abl
downregul
transgen
express
hepat
b
viru
surfac
antigen
transgen
mice
subsequ
report
comparison
efficaci
dna
vaccin
dna
vaccin
deliv
liveattenu
salmonella
system
recombin
protein
vaccin
gener
protect
immun
respons
penicillium
marneffei
thermal
dimorph
fungu
infect
hiv
posit
patient
china
southeast
asia
mous
model
result
show
similar
hepat
b
viru
dna
vaccin
present
liveattenu
salmonella
system
p
marneffei
dna
vaccin
deliv
liveattenu
salmonella
system
gener
good
antibodi
respons
wherea
intramuscular
dna
vaccin
gener
best
protect
immun
p
marneffei
infect
impli
cellular
humor
immun
respons
import
protect
p
marneffei
infect
present
studi
observ
line
result
hepat
b
viru
dna
vaccin
p
marneffei
dna
vaccin
deliv
liveattenu
salmonella
system
spike
polypeptid
dna
vaccin
deliv
liveattenu
salmonella
system
induc
good
antibodi
respons
fig
tabl
group
although
mice
develop
high
antibodi
level
spike
protein
boost
speptid
fig
group
antibodi
neutral
cell
cultur
system
tabl
group
may
due
ineffect
dna
vaccin
deliv
liveattenu
salmonella
system
prime
develop
neutral
antibodi
correct
configur
nonneutr
antibodi
spike
protein
elicit
respons
subsequ
recombin
speptid
